CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Xvivo Perfusion AB is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Xvivo Perfusion AB
Massans gata 10
Phone: +46 317882150p:+46 317882150 GOETEBORG, 412 51  Sweden Ticker: XVIVOXVIVO
Business Summary
Xvivo Perfusion AB is a Sweden-based medical technology company focused on developing optimized solutions for organ, tissue and cell preservation in connection with transplantation. The Company operates in two segments: Durable goods and Non-Durable goods. The Durable goods segment comprises sale and rental income from XVIVO Perfusion System (XPS) machines. The Non-Durable goods segment implies revenue from the sale of products and services that are solutions and disposable items. The Company’s product portfolio consists of Perfadex, STEEN Solution, XPS, XPS Disposable Kit, XVIVO Lung Cannula Set, XVIVO Organ Chamber, XPS PGM Disposable Sensors and Silicone Tubing Set. The Company markets its products in Europe, Asia, Middle East, and North & South America.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-Yes---

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
9/30/202412/31/2023Yes----

Industries
SIC Code Description
3842 Orthopedic, prosthetic, and surgical appliances and supplies
3841 Surgical and medical instruments and apparatus
2834 Pharmaceutical preparations

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chairman of the Board Gosta E.Johannesson 65 4/27/2018 1/1/2013
Chief Executive Officer ChristofferRosenblad 49 11/30/2022 1/1/2012
Deputy Chief Executive Officer, Chief Operating Officer LenaHagman 59 11/14/2024 1/1/2022
10 additional Officers and Directors records available in full report.

Subsidiaries
Business Name Address City State/Province Country
Vivoline Medical AB Propellervagen 16 LUND Sweden
Xvivo Perfusion Inc 7403 Solution Center Chicago 60677 USA

Business Names
Business Name
0RKL
Star Teams Inc.
Vivoline Medical AB
XVIPY
XVIVO
Xvivo Perfusion Inc

General Information
Number of Employees: 161 (As of 9/30/2024)
Outstanding Shares: 31,499,470 (As of 9/30/2024)
Shareholders: 8,826
Stock Exchange: STO
Fax Number: +46 317882169


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Monday, December 2, 2024